Stay updated on BMS-986340 in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BMS-986340 in Advanced Solid Tumors Clinical Trial page.

Latest updates to the BMS-986340 in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe page now displays the latest revision label (v3.6.5) indicating an updated version of the page, replacing the previous revision (v3.6.4).SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor software update applied to the page. This change does not modify displayed study details or core functionality.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedTwo new local institutions (0016 and 0030) were added with a Completed status and a revision tag v3.6.3; several site contacts and center names were removed, indicating an update to recruitment points of contact and site listings.SummaryDifference0.4%

- Check49 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2. This reflects a new revision of the ClinicalTrials.gov page, likely containing minor edits or clarifications but not changes to the study data.SummaryDifference0.0%

- Check63 days agoChange DetectedNew help and join-related sections were added to the study page navigation, including 'Check who can join', 'Find Contact Information', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', along with a new version tag 'Revision: v3.6.0'. The label for the Interventions section was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment' and the older revision entry 'Revision: v3.5.5' was removed.SummaryDifference0.2%

- Check70 days agoChange DetectedThe study record now describes a Phase 1/2 study of BMS-986340 as monotherapy and in combination with Pumitamig, with expanded endpoints and updated enrollment across more locations. A previous version involving combinations with nivolumab or docetaxel was removed.SummaryDifference2%

Stay in the know with updates to BMS-986340 in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986340 in Advanced Solid Tumors Clinical Trial page.